Nederlands
English
About VIB
Currently selected
Science communication
Home
>
About VIB
>
Press
Refine
Theme
About VIB (92)
Arabidopsis (3)
Bioinformatics (11)
Biotech basics (1)
Cancer (68)
Cardiovascular medicine (11)
Cell biology (9)
Grand Challenges (2)
Immunology (32)
Inflammation and immunity (53)
Microbiology (21)
Model Organisms (4)
Mouse (2)
Neuroscience (58)
Plant biology (41)
Proteomics (5)
Research Areas (3)
Science ethics (2)
Structural biology (17)
Systems biology (2)
Yeast (1)
Category
BioInformatics Training and Service facility (1)
Business opportunities (8)
Developmental biology (1)
Event (8)
News (34)
Research services (5)
Page Content Zone 1
Press
Receive VIB press releases
Email updates
Follow us on Twitter
Like us on Facebook
RSS
Contact
For all press inquiries, contact
VIB
Tel.: +32 9 244 66 11
info@vib.be
Recent press releases
Going beyond the helpdesk. The extended offer of VIB core facilities
20 March 2019
Whoever assumes that VIB core facilities only provide executive services is greatly mistaken. Today, their focus lies on helping biologists expand their knowledge and use state-of-the-art technologies.
At the interface of proteomics and metabolomics
20 March 2019
Despite their differing research disciplines, the VIB Metabolomics Core and the VIB Proteomics Core often cross each other’s paths. Cutting-edge mass spectrometry (MS) takes credit for this.
Hungry for hops or technology intelligence? VIB alumnus Mark Veugelers is your man
19 March 2019
Senior Science Policy Manager Mark Veugelers left VIB in August 2017 to follow his two passions: beer and life science technologies. With Enigma Life Sciences Mark provides key technology intelligence and strategic advice to customers worldwide
High-throughput screening underpins drug discovery
19 March 2019
Whether they conduct yeast, plant or animal research, scientists are likely to be confronted with test systems that are too complex for screening. The VIB Screening Core remedies this situation by optimizing and miniaturizing assays.
Our Core Facilities
19 March 2019
All VIB Core Facilities
An integrated technology ecosystem that comes to fruition at VIB
18 March 2019
VIB is active in several life science disciplines, associated in several centers. Though, rather than operating independently, the various centers, labs and cores act together in an ecosystem built upon advanced technology integration.
The VIB technology ecosystem
18 March 2019
Profiling the immune system in paediatric arthritis patients offers hope for improved diagnosis and treatment
13 March 2019
A team of scientists from VIB and KU Leuven has developed a machine learning algorithm that identifies children with juvenile arthritis with almost 90% accuracy from a simple blood test.
Mission Bio joins forces with VIB to revolutionize single-cell DNA analysis
7 March 2019
Differences in the mutational background of individual cancer cells within the same tumor can influence their sensitivity to the targeted treatment, and residual resistant cells can remain present after eradication of most of the tumor.
Breast cancer cells rely on pyruvate to expand in new tissues
4 March 2019
Cancer cells alter their metabolism to grow and expand across other organs. A study by Sarah-Maria Fendt & team (VIB-KU Leuven Center for Cancer Biology) shown that breast cancer cells require the nutrient pyruvate to do this.
VIB welcomes new Marie Curie fellows
4 March 2019
Each year, the EU launches calls for postdoc research fellowships through the Marie Sklodowksa-Curie Actions. Fellowships provided through these actions support researchers regardless of age & nationality.
Kick-off for the new EU project ENDOSCAPE
27 February 2019
VIB participates in the EU-funded ENDOSCAPE project, a research and innovation action that aims to develop a novel gene delivery technology. ENDOSCAPE is a 6.8 M€ project funded by the European Union’s Horizon 2020 Research and Innovation programme.
VIB, CD3 and Beactica announce drug discovery alliance targeting inflammatory diseases
26 February 2019
VIB, KU Leuven’s Centre for Drug Design and Discovery (CD3) and Beactica AB are proud to announce a new partnership. The three parties will be working together in a drug discovery project to address critical unmet needs in the area of inflammation.
Agilent Presents Thought Leader Award to Professor Diether Lambrechts
20 February 2019
Agilent Technologies Inc. (NYSE: A) today announced that Professor Diether Lambrechts from the VIB-KU Leuven Center for Cancer Biology has received an Agilent Thought Leader Award in support of his research in cancer genomics.
New insights into radial expansion of plants can boost biomass production
8 February 2019
Besides the longitudinal growth, plants also enlarge in the radial sense. This thickening of plant stems & roots provides physical support to plants, provides us with wood and cork & plays a role in sequestering atmospheric carbon into plant biomass
«Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
Next»
Page Content Zone 2
Page Content Zone 3